You are here

Home › Clinical outcomes worse for young, immunocompromised COVID patients --study › Clinical outcomes worse for young, immunocompromised COVID patients --study

Clinical outcomes worse for young, immunocompromised COVID patients --study

Primary tabs

Clinical outcomes worse for young, immunocompromised COVID patients --study

Tue, 2024-03-19 09:31 — mike kraft
Clinical outcomes worse for young, immunocompromised COVID patients In a national case series, 11.4% of immunocompromised patients younger than 21 years with COVID-19 admitted for intensive care died, compared to 4.6% of their peers with healthy immune systems. CIDRAP

...

In addition to almost triple the rate of in-hospital mortality, patients with ICCs had longer hospital stays.

...

Country / Region Tags: 
Cambodia
United States
General Topic Tags: 
COVID-19
Symptoms
Children
Data
Health
Hospitals
Public Health
Problem, Solution, SitRep, or ?: 
Analysis
Groups this Group Post belongs to: 
Global Health
Medical - global
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Commentaire Operations
No state No state
howdy folks
Page loaded in 0.579 seconds.